Radicle Rest 2: A Study of Health and Wellness Products on Sleep and Health Outcomes

Sleep Clinical Trial

Official title: Radicle™ Rest 2: A Randomized, Blinded, Placebo-Controlled Direct-to-Consumer Study of Health and Wellness Products on Sleep and Other Health Outcomes

Status Completed

Clinical Trial Summary

A randomized, blinded, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on sleep and other health outcomes.

Clinical Trial Description

This is a randomized, blinded, placebo-controlled study conducted with adult participants, age 21 and older and residing in the United States.

Eligible participants will (1) endorse a desire for improved sleep, (2) indicate an interest in taking a health and wellness product to potentially help their sleep, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study.

Participants with known liver or kidney disease, heavy drinkers, and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking certain medications will be excluded.

Self-reported data are collected electronically from eligible participants over 7 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study. ;

Related Conditions & MeSH terms

• Sleep
• Sleep Disorder
• Sleep Disturbance
• Sleep Wake Disorders

• NCT number: NCT05657808
• Study type: Interventional
• Source: Radicle Science
• Status: Completed
• Phase: N/A
• Start date: January 9, 2023
• Completion date: April 15, 2024